Breaking News Instant updates and real-time market news.

2020-12-03 04:55:00 CNDT Conduent $4.38 / +0.1 (+2.34%) 04:55 12/03/20 12/03 04:55 12/03/20 04:55	Conduent management to meet virtually with Needham Virtual Meeting to be held on December 3 hosted by Needham.	03 Dec
CNDT Conduent $4.38 / +0.1 (+2.34%) 04/14/20 JPMorgan JPMorgan downgrades Conduent to Neutral with turnaround 'stretched' by pandemic 04/13/20 JPMorgan Conduent downgraded to Neutral from Overweight at JPMorgan

2020-12-03 04:55:00

CNDT

Conduent

$4.38 / +0.1 (+2.34%)

04:55

12/03/20

12/03

04:55

12/03/20

04:55

Conduent management to meet virtually with Needham

Virtual Meeting to be held on December 3 hosted by Needham.

03
Dec

CNDT Conduent

$4.38 / +0.1 (+2.34%)

04/14/20 JPMorgan: JPMorgan downgrades Conduent to Neutral with turnaround 'stretched' by pandemic

04/13/20 JPMorgan: Conduent downgraded to Neutral from Overweight at JPMorgan

TODAY'S FREE FLY STORIES

Downgrade	Ecopetrol downgraded to Sell from Neutral at BTG Pactual » 11:37 01/27/21 01/27 11:37 01/27/21 11:37 EC Ecopetrol $12.40 / -0.73 (-5.56%) BTG Pactual analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings EC Ecopetrol $12.40 / -0.73 (-5.56%) 12/14/20 Ecopetrol to invest $3.5B-$4B in 2021 11/17/20 Ecopetrol announces settlement between subsidiaries and Frontera EC Ecopetrol $12.40 / -0.73 (-5.56%) 01/06/21 Fly Intel: Top five analyst downgrades 01/06/21 UBS Ecopetrol downgraded to Neutral from Buy at UBS 12/11/20 Citi Ecopetrol price target raised to $14.70 from $13 at Citi 11/24/20 JPMorgan Ecopetrol downgraded to Neutral from Overweight at JPMorgan EC Ecopetrol $12.40 / -0.73 (-5.56%) 10/27/20 Ecopetrol reports Q2 EBITDA COP 2.0B vs. COP 8.3B last year
Hot Stocks	VG Acquisition halted for volatility after jumping 18% on 23AndMe report 11:35 01/27/21 01/27 11:35 01/27/21 11:35 VGAC VG Acquisition $13.25 / -0.45 (-3.28%) ShowHide Related Items >><< Company News Periodicals On The Fly Options VGAC VG Acquisition $13.25 / -0.45 (-3.28%) 11:34 Today VG Acquisition Corp trading halted, volatility trading pause VGAC VG Acquisition $13.25 / -0.45 (-3.28%) 11:35 Today VG Acquisition in talks to take 23AndMe public, Bloomberg reports VGAC VG Acquisition $13.25 / -0.45 (-3.28%) 10/04/20 Opening Day: Palantir, Asana go public via direct listings VGAC VG Acquisition $13.25 / -0.45 (-3.28%) 12/23/20 new option listings and one option delisting on December 23rd
Periodicals	VG Acquisition in talks to take 23AndMe public, Bloomberg reports 11:35 01/27/21 01/27 11:35 01/27/21 11:35 VGAC VG Acquisition $13.17 / -0.53 (-3.87%) ShowHide Related Items >><< Company News On The Fly Options VGAC VG Acquisition $13.17 / -0.53 (-3.87%) 11:34 Today VG Acquisition Corp trading halted, volatility trading pause VGAC VG Acquisition $13.17 / -0.53 (-3.87%) 10/04/20 Opening Day: Palantir, Asana go public via direct listings VGAC VG Acquisition $13.17 / -0.53 (-3.87%) 12/23/20 new option listings and one option delisting on December 23rd
Hot Stocks	VG Acquisition Corp trading halted, volatility trading pause 11:34 01/27/21 01/27 11:34 01/27/21 11:34 VGAC VG Acquisition $13.12 / -0.58 (-4.23%) ShowHide Related Items >><< On The Fly Options VGAC VG Acquisition $13.12 / -0.58 (-4.23%) 10/04/20 Opening Day: Palantir, Asana go public via direct listings VGAC VG Acquisition $13.12 / -0.58 (-4.23%) 12/23/20 new option listings and one option delisting on December 23rd
Recommendations	Altius Minerals price target raised to C$17.50 from C$16.50 at Canaccord » 11:31 01/27/21 01/27 11:31 01/27/21 11:31 ATUSF Altius Minerals $0.00 / + (+0.00%) Canaccord analyst Carey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research ATUSF Altius Minerals $0.00 / + (+0.00%) 10/13/20 ARR enters relationship with Apollo Global for renewable energy royalty business 10/13/20 Apollo Infrastructure Funds, Altius Renewable Royalties announce joint venture ATUSF Altius Minerals $0.00 / + (+0.00%) 01/15/21 Raymond James Altius Minerals price target raised to C$16.50 from C$14.50 at Raymond James 01/11/21 Scotiabank Altius Minerals price target raised to C$16 from C$12.50 at Scotiabank 11/18/20 Scotiabank Altius Minerals price target lowered to C$12.50 from C$13 at Scotiabank 11/13/20 Scotiabank Altius Minerals price target raised to C$13 from C$12.50 at Scotiabank

Recommendations	Canadian National price target lowered to $117 from $124 at Credit Suisse » 11:30 01/27/21 01/27 11:30 01/27/21 11:30 CNI Canadian National $102.05 / -5.09 (-4.75%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CNI Canadian National $102.05 / -5.09 (-4.75%) 01/26/21 Canadian National announces share repurchase and 7% boost to 2021 dividend 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 CNI Canadian National $102.05 / -5.09 (-4.75%) 10:40 Today National Bank Canadian National price target lowered to C$137 from C$141 at National Bank 10:34 Today Scotiabank Canadian National price target lowered to C$140 from C$144 at Scotiabank 10:32 Today TD Securities Canadian National price target lowered to C$160 from C$165 at TD Securities 08:25 Today Credit Suisse Canadian National price target lowered to $117 from $124 at Credit Suisse CNI Canadian National $102.05 / -5.09 (-4.75%) 01/26/21 Canadian National sees FY21 adjusted EPS up high-single digits 01/26/21 Canadian National reports Q4 adjusted EPS C$1.43 vs. C$1.25 last year 10/20/20 Canadian National reports Q3 EPS $C$1.38 versus $C1.66 in Q319
Recommendations	Keyera price target raised to C$30 from C$28 at Credit Suisse » 11:29 01/27/21 01/27 11:29 01/27/21 11:29 KEYUF Keyera $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research KEYUF Keyera $0.00 / + (+0.00%) 08/28/20 Pipestone Energy announces extension to unplanned outage at Keyera plant KEYUF Keyera $0.00 / + (+0.00%) 10:48 Today National Bank Keyera price target raised to C$29 from C$27 at National Bank 01/19/21 Stifel Keyera price target raised to C$27 from C$25 at Stifel 01/13/21 CIBC Keyera price target raised to C$29 from C$27 at CIBC 11/05/20 CIBC Keyera price target lowered to C$27 from C$28 at CIBC
Recommendations	Pembina Pipeline price target raised to C$42 from C$40 at Credit Suisse » 11:29 01/27/21 01/27 11:29 01/27/21 11:29 PBA Pembina Pipeline $26.89 / -0.34 (-1.25%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events PBA Pembina Pipeline $26.89 / -0.34 (-1.25%) 01/19/21 Pembina Pipeline announces binding open season 12/14/20 Pembina Pipeline sees FY21 CapEx $730M 12/14/20 Pembina Pipeline sees 2021 adjusted EBITDA $3.2B-$3.4B PBA Pembina Pipeline $26.89 / -0.34 (-1.25%) 10:49 Today National Bank Pembina Pipeline price target raised to C$38 from C$36 at National Bank 01/22/21 Stifel Pembina Pipeline price target raised to C$37 from C$34 at Stifel 01/13/21 CIBC Pembina Pipeline price target raised to C$40 from C$38 at CIBC 12/15/20 BMO Capital Pembina Pipeline downgraded to Market Perform from Outperform at BMO Capital 02/26/21 Pembina Pipeline - PBA
Hot Stocks	Commvault says on path to deliver over 25% EBITDA through FY23 » 11:27 01/27/21 01/27 11:27 01/27/21 11:27 CVLT Commvault $57.39 / -3.3 (-5.44%) Says positioned to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CVLT Commvault $57.39 / -3.3 (-5.44%) 10/27/20 Commvault says ransomware 'top of mind' with customers 10/27/20 Commvault sees 'cloud-first' strategy leading return to growth 09/15/20 Commvault achieves AWS Outposts Ready designation 09/03/20 Sify Technologies partners with Commvault for unified data protection CVLT Commvault $57.39 / -3.3 (-5.44%) 01/25/21 Needham Commvault price target raised to $66 from $60 at Needham 01/13/21 KeyBanc Commvault upgraded to Overweight on upcoming catalysts at KeyBanc 01/13/21 KeyBanc Commvault upgraded to Overweight from Sector Weight at KeyBanc 01/12/21 Piper Sandler Commvault upgraded to Overweight from Neutral at Piper Sandler CVLT Commvault $57.39 / -3.3 (-5.44%) 11:22 Today Commvault sees Q4 EPS 46c, consensus 47c 07:46 Today Commvault reports Q3 non-GAAP EPS 57c, consensus 47c 10/27/20 Commvault sees Q3 revenue $174M-$176M, consensus $172.9M 10/27/20 Commvault reports Q2 non-GAAP EPS 45c, consensus 35c 11:00 Today Commvault - CVLT 00:00 Today Commvault
Hot Stocks	PSEG approved to develop electric vehicle charging in New Jersey » 11:26 01/27/21 01/27 11:26 01/27/21 11:26 PEG PSEG $57.50 / -0.85 (-1.46%) The New Jersey Board of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PEG PSEG $57.50 / -0.85 (-1.46%) 01/26/21 PSEG raises dividend 2.7% to 43c 12/04/20 PSEG to acquire 25% interest in Ocean Wind project 10/15/20 PSEG's Nuclear's Salem Unit 1 conducts planned refueling, maintenance outage 09/23/20 PSEG reports New Jersey BPU approval for 'centerpiece' of proposal PEG PSEG $57.50 / -0.85 (-1.46%) 01/14/21 Goldman Sachs PSEG upgraded to Buy from Neutral at Goldman Sachs 01/08/21 Mizuho PSEG price target lowered to $56 from $57 at Mizuho 11/18/20 Barclays PSEG price target raised to $65 from $59 at Barclays 10/09/20 Mizuho PSEG price target raised to $57 from $56 at Mizuho PEG PSEG $57.50 / -0.85 (-1.46%) 10/30/20 PSEG narrows FY20 adjusted EPS view to $3.35-$3.50 from $3.30-$3.50 10/30/20 PSEG reports Q3 adjusted EPS 96c, consensus 97c 07/31/20 PSEG backs FY20 adjusted EPS view $3.30-$3.50, consensus $3.36 07/31/20 PSEG reports Q2 adjusted EPS 79c, consensus 60c

Syndicate	Shoals Technologies indicated to open at $29.90, IPO priced at $25 11:26 01/27/21 01/27 11:26 01/27/21 11:26 SHLS Shoals Technologies $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 27 Jan
Options	Palantir Technologies call volume above normal and directionally bullish » 11:25 01/27/21 01/27 11:25 01/27/21 11:25 PLTR Palantir $38.41 / +3.005 (+8.49%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PLTR Palantir $38.41 / +3.005 (+8.49%) 01/19/21 PG&E begins deployment of Palantir's Foundry Software 01/13/21 Palantir awarded contract from Army worth up to $250M 01/06/21 Fujitsu signs $8M contract as Palantir Foundry customer 01/04/21 Palantir awarded $22.5M contract contract in partnership with SOMPO Holdings PLTR Palantir $38.41 / +3.005 (+8.49%) 01/21/21 Fly Intel: Top five analyst initiations 01/20/21 Fly Intel: Top five analyst initiations 01/20/21 William Blair Palantir initiated with a Market Perform at William Blair 01/13/21 Fly Intel: Top five analyst downgrades PLTR Palantir $38.41 / +3.005 (+8.49%) 11/12/20 Palantir sees Q4 revenue $299M-$301M, consensus $296.03M 11/12/20 Palantir raises FY20 revenue view to $1.07B-$1.072B, consensus $1.06B 11/12/20 Palantir reports Q3 EPS (94c) vs (24c) last year 09/22/20 Palantir sees FY21 revenue growth greater than 30% PLTR Palantir $38.41 / +3.005 (+8.49%) 01/13/21 Pentagon cybersecurity project slowed by flaws, Bloomberg says 11/27/20 Citron shorting Palantir, sees $20 stock by end of 2020 11/17/20 Soros reveals stake in Palantir, but plans to sell it, CNN Business reports 11/06/20 Hedgeye adds Palantir to best idea short list, Bloomberg says PLTR Palantir $38.41 / +3.005 (+8.49%) 01/13/21 Citi says sell Palantir on deceleration in growth, upcoming lockup expiry 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 12/18/20 Palantir downgrade at Credit Suisse among today's top calls on Wall Street PLTR Palantir $38.41 / +3.005 (+8.49%) 01/15/21 Palantir Technologies call volume above normal and directionally bullish 01/08/21 Palantir Technologies call volume above normal and directionally bullish 01/08/21 Largest borrow rate increases among liquid names 01/06/21 Largest borrow rate increases among liquid names
Conference/Events	Midwest Energy Emissions to host conference call » 11:25 01/27/21 01/27 11:25 01/27/21 11:25 MEEC Midwest Energy Emissions $0.00 / + (+0.00%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Events MEEC Midwest Energy Emissions $0.00 / + (+0.00%) 01/19/21 Midwest Energy Emissions reaches license agreement with North American utility 01/11/21 Midwest Energy Emissions announces agreement with major national utility 12/01/20 Midwest Energy Emissions, AEP sign agreement for non-exclusive license 10/19/20 Midwest Energy Emissions engages MZ Group to lead investor relations MEEC Midwest Energy Emissions $0.00 / + (+0.00%) 11/24/20 Midwest Energy Emissions reports Q3 EPS (1c) vs. (1c) last year 11:30 Today Midwest Energy Emissions - MEEC
Earnings	Commvault sees Q4 EPS 46c, consensus 47c » 11:22 01/27/21 01/27 11:22 01/27/21 11:22 CVLT Commvault $57.60 / -3.09 (-5.09%) Sees Q4 revenue $182M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CVLT Commvault $57.60 / -3.09 (-5.09%) 10/27/20 Commvault says ransomware 'top of mind' with customers 10/27/20 Commvault sees 'cloud-first' strategy leading return to growth 09/15/20 Commvault achieves AWS Outposts Ready designation 09/03/20 Sify Technologies partners with Commvault for unified data protection CVLT Commvault $57.60 / -3.09 (-5.09%) 01/25/21 Needham Commvault price target raised to $66 from $60 at Needham 01/13/21 KeyBanc Commvault upgraded to Overweight on upcoming catalysts at KeyBanc 01/13/21 KeyBanc Commvault upgraded to Overweight from Sector Weight at KeyBanc 01/12/21 Piper Sandler Commvault upgraded to Overweight from Neutral at Piper Sandler CVLT Commvault $57.60 / -3.09 (-5.09%) 07:46 Today Commvault reports Q3 non-GAAP EPS 57c, consensus 47c 10/27/20 Commvault sees Q3 revenue $174M-$176M, consensus $172.9M 10/27/20 Commvault reports Q2 non-GAAP EPS 45c, consensus 35c 07/28/20 Commvault sees Q2 revenue approx. $164M, consensus $159.98M 11:00 Today Commvault - CVLT 00:00 Today Commvault
Recommendations	ECN Capital price target raised to C$8.25 from C$7 at Raymond James » 11:21 01/27/21 01/27 11:21 01/27/21 11:21 ECNCF ECN Capital $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ECNCF ECN Capital $0.00 / + (+0.00%) 01/26/21 CIBC ECN Capital price target raised to C$8.25 from C$7 at CIBC 01/25/21 National Bank ECN Capital price target raised to C$9 from C$7.50 at National Bank 01/19/21 Stifel ECN Capital price target raised to C$9 from C$7.50 at Stifel 11/12/20 RBC Capital ECN Capital price target raised to C$7.50 from C$7 at RBC Capital

Syndicate	CA Healthcare Acquisition opens at $10.20, IPO priced at $10 » 11:18 01/27/21 01/27 11:18 01/27/21 11:18 CAHC CA Healthcare Acquisition $0.00 / + (+0.00%) CA Healthcare Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Technical Analysis	NASDAQ market internals summary » 11:17 01/27/21 01/27 11:17 01/27/21 11:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 Today NASDAQ market internals summary 01/26/21 NASDAQ market internals summary 01/26/21 NASDAQ market internals summary 01/26/21 NASDAQ market internals summary
On The Fly	Fly Intel: What to watch in Facebook earnings report » 11:16 01/27/21 01/27 11:16 01/27/21 11:16 FB Facebook $276.65 / -5.36 (-1.90%) , AAPL Apple $143.20 / +0.03 (+0.02%) Facebook (FB) is… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FB AAPL FB Facebook $276.65 / -5.36 (-1.90%) 01/21/21 Facebook: Trump's access to remain suspended 'indefinitely' 01/21/21 Facebook referrering former President Trump's suspension to Oversight Board 01/11/21 Facebook to remove content containing phrase 'stop the steal' 01/11/21 Airbnb says its PAC will 'withhold support' from those who opposed certification AAPL Apple $143.20 / +0.03 (+0.02%) 01/25/21 Apple names hardware chief Dan Riccio to lead 'new project' 01/25/21 Apple warns magnets in iPhone 12, MagSafe devices may impact pacemakers 01/21/21 VirnetX submits agreed BOC, prejudgement interest of $75.7M in Apple suit 01/19/21 Netflix says past year 'testament' to company's approach FB AAPL FB Facebook $276.65 / -5.36 (-1.90%) 01/26/21 Morgan Stanley Morgan Stanley work finds 'modestly rising' U.S. use of IG Shopping and Reels 01/26/21 Deutsche Bank Deutsche ups Facebook target to $350, sees upcoming Q4 as 'clearing event' 01/26/21 Piper Sandler Facebook Q4 results Wednesday should be 'strong,' says Piper Sandler 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value AAPL Apple $143.20 / +0.03 (+0.02%) 01/26/21 Credit Suisse Credit Suisse could see software, battery as key underpinnings of Apple car 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value 01/25/21 Evercore ISI Evercore ISI raises Apple price target to $160, sees higher odds of car product 01/25/21 Raymond James Apple price target raised to $150 from $140 at Raymond James FB AAPL FB Facebook $276.65 / -5.36 (-1.90%) 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 10/29/20 Facebook reports Q3 EPS $2.71, consensus $1.91 10/29/20 Notable companies reporting after market close 07/30/20 Facebook reports Q2 EPS $1.80, consensus $1.39 AAPL Apple $143.20 / +0.03 (+0.02%) 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year 10/29/20 Apple reports Q4 iPhone revenue $24.44B vs. $33.36B last year 10/29/20 Apple reports Q4 EPS 73c, consensus 70c FB AAPL FB Facebook $276.65 / -5.36 (-1.90%) 01/23/21 Big tech stocks are back, Barron's says 01/22/21 Facebook memo told employees to prioritize privacy, OneZero reports 01/21/21 Apple's first headset to focus on virtual reality, Bloomberg reports 01/20/21 Facebook rival MeWe adds 2.5M privacy-seeking users in a week, USA Today says AAPL Apple $143.20 / +0.03 (+0.02%) 01/25/21 Apple sued in Italy over throttled iPhone 6 devices, TechCrunch says 01/23/21 Big tech stocks are back, Barron's says 01/22/21 Foxconn said to receive extra iPhone 12 Pro orders, DigiTimes reports 01/21/21 Apple's first headset to focus on virtual reality, Bloomberg reports FB AAPL FB Facebook $276.65 / -5.36 (-1.90%) 01/26/21 Bed Bath & Beyond up again as UBS says sell, take profits after rally 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/19/21 Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades AAPL Apple $143.20 / +0.03 (+0.02%) 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/20/21 Street Fight: Analysts diverge on Lumentum after Coherent deal announcement 01/19/21 Lumentum slides after announcing $5.7B merger deal with Coherent 01/19/21 Facebook upgrade, Roku initiation among today's top calls on Wall Street 17:00 Today Facebook - FB 17:00 Today Apple - AAPL 02/23/21 Apple, Inc. FB AAPL FB Facebook $276.65 / -5.36 (-1.90%) 01/15/21 Facebook call volume above normal and directionally bullish 12/21/20 Facebook call buyer realizes 33% same-day gains 12/10/20 Unusually active option classes on open December 10th 12/07/20 Facebook call volume above normal and directionally bullish AAPL Apple $143.20 / +0.03 (+0.02%) 01/26/21 Notable open interest changes for January 26th 01/25/21 Notable open interest changes for January 25th 01/22/21 Notable open interest changes for January 22nd 01/21/21 Notable open interest changes for January 21st
Syndicate	Shoals Technologies indicated to open at $28, IPO priced at $25 11:16 01/27/21 01/27 11:16 01/27/21 11:16 SHLS Shoals Technologies $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 27 Jan
Technical Analysis	NYSE market internals summary » 11:16 01/27/21 01/27 11:16 01/27/21 11:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 10:16 Today NYSE market internals summary 01/26/21 NYSE market internals summary 01/26/21 NYSE market internals summary 01/26/21 NYSE market internals summary

Hot Stocks	Boeing still expects to be cash flow positive in 2022 11:15 01/27/21 01/27 11:15 01/27/21 11:15 BA Boeing $196.63 / -5.45 (-2.70%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $196.63 / -5.45 (-2.70%) 11:12 Today Boeing sees 2021 revenue improving from 2020 11:12 Today Boeing: 2021 to continue to be challenging, but sees upward trends from 2020 11:11 Today Boeing operating cash 'much improved' in 2021 vs. 2020 11:03 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA BA Boeing $196.63 / -5.45 (-2.70%) 01/20/21 Fly Intel: Top five analyst upgrades 01/20/21 Berenberg Boeing upgraded to Hold from Sell at Berenberg 01/04/21 Fly Intel: Top five analyst downgrades 01/04/21 Baird Boeing elevated to Fresh Pick at Baird BA Boeing $196.63 / -5.45 (-2.70%) 07:30 Today Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BA Boeing $196.63 / -5.45 (-2.70%) 01/25/21 Boeing 737 MAX set to take flight in Europe this week, Reuters reports 01/13/21 Emirates President: Boeing 777X entry likely in 2023 or later, Reuters says 01/13/21 Boeing's drone unit to pay $25M to settle civil fraud allegations, WSJ reports 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports BA Boeing $196.63 / -5.45 (-2.70%) 09:08 Today Fly Intel: Pre-market Movers 01/20/21 Netflix upgrades, Tesla target hike among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 10:30 Today Boeing - BA BA Boeing $196.63 / -5.45 (-2.70%) 12/07/20 Early notable gainers among liquid option names on December 7th 12/03/20 Unusually active option classes on open December 3rd 12/02/20 Boeing call volume above normal and directionally bullish 11/19/20 Notable open interest changes for November 19th
Options	Nutanix put volume heavy and directionally bearish » 11:15 01/27/21 01/27 11:15 01/27/21 11:15 NTNX Nutanix $31.97 / -0.48 (-1.48%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options NTNX Nutanix $31.97 / -0.48 (-1.48%) 12/29/20 VMware initiates legal proceedings against former COO for breach of contract 12/09/20 Nutanix appoints Rajiv Ramaswami as CEO 09/08/20 Nutanix rallies after inking new cloud partnership with Microsoft 09/08/20 Nutanix partners with Microsoft Azure for hybrid solution NTNX Nutanix $31.97 / -0.48 (-1.48%) 01/13/21 William Blair VMware downgraded to Market Perform at William Blair after executive exits 12/14/20 Oppenheimer Nutanix upgraded to Outperform at Oppenheimer 12/14/20 Oppenheimer Nutanix upgraded to Outperform from Perform at Oppenheimer 12/09/20 William Blair New Nutanix CEO a 'best-of-both-worlds pick,' says William Blair NTNX Nutanix $31.97 / -0.48 (-1.48%) 11/23/20 Nutanix reports Q1 adjusted EPS (44c), consensus (57c) 11/23/20 Nutanix sees Q2 ACV billings $145M-$148M 11/23/20 Notable companies reporting after market close 08/27/20 Nutanix reports Q4 adjusted EPS (39c), consensu (67c) NTNX Nutanix $31.97 / -0.48 (-1.48%) 01/13/21 VMware slides as Gelsinger returns to Intel to be new CEO 11/23/20 Fly Intel: After-Hours Movers 09/08/20 Fly Intel: Wall Street's top stories for Tuesday 08/28/20 Fly Intel: Wall Street's top stories for Friday NTNX Nutanix $31.97 / -0.48 (-1.48%) 11/23/20 Nutanix options imply 18.4% move in share price post-earnings 11/10/20 Nutanix put volume heavy and directionally bearish 10/26/20 Nutanix put volume heavy and directionally bearish 10/14/20 Nutanix call volume above normal and directionally bullish
Hot Stocks	Cel Sci trading resumes 11:14 01/27/21 01/27 11:14 01/27/21 11:14 CVM CEL-SCI $17.00 / +2.46 (+16.92%) ShowHide Related Items >><< Company News Street Research Periodicals Options CVM CEL-SCI $17.00 / +2.46 (+16.92%) 11:09 Today Cel Sci trading halted, volatility trading pause 12/07/20 CEL-SCI announces update on Phase 3 cancer trial results 12/01/20 CEL-SCI's LEAPS peptides demonstrate clear survival benefit in COVID treatment 09/18/20 CEL-SCI awarded European patent for LEAPS vaccine in treatment of RA CVM CEL-SCI $17.00 / +2.46 (+16.92%) 05/14/20 H.C. Wainwright CEL-SCI price target raised to $23 from $18 at H.C. Wainwright CVM CEL-SCI $17.00 / +2.46 (+16.92%) 09/15/20 CEL-SCI a 'highly compelling short candidate,' MRC says in short report 09/15/20 CEL-SCI delay 'a smokescreen' to 'cover up' study failure, Feuerstein says CVM CEL-SCI $17.00 / +2.46 (+16.92%) 01/20/21 Largest borrow rate increases among liquid names 01/19/21 Largest borrow rate increases among liquid names 01/11/21 Cel Sci put volume heavy and directionally bearish 12/29/20 Cel Sci put volume heavy and directionally bearish
Recommendations	Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program » 11:13 01/27/21 01/27 11:13 01/27/21 11:13 VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) , LLY Eli Lilly $208.50 / -4.4 (-2.07%) , GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) After Vir Biotechnology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 11:04 Today Vir Biotechnology trading resumes 10:59 Today Vir Biotechnology trading halted, volatility trading pause 06:49 Today Eli Lilly, Vir and GlaxoSmithKline announce collaboration 06:48 Today Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail LLY Eli Lilly $208.50 / -4.4 (-2.07%) 07:30 Today AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid 06:49 Today Eli Lilly, Vir and GlaxoSmithKline announce collaboration 06:48 Today Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail 01/26/21 Eli Lilly: Etesevimab, bamlanivimab reduced risk of Covid hospitalizations GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 08:32 Today Sanofi's priority is to continue to develop two Covid vaccine candidates 07:30 Today AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid 06:49 Today Eli Lilly, Vir and GlaxoSmithKline announce collaboration 06:48 Today Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 07:00 Today JPMorgan Vir Biotechnology downgraded to Underweight after 70% rally at JPMorgan 04:52 Today JPMorgan Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan 01/20/21 H.C. Wainwright Vir Biotechnology price target raised to $125 from $100 at H.C. Wainwright 12/24/20 Baird Baird maintains 'profound skepticism' of Vir's COVID antibody after Lilly data LLY Eli Lilly $208.50 / -4.4 (-2.07%) 01/26/21 Berenberg Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg 01/20/21 Citi Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data 01/19/21 Roth Capital Merus price target raised to $32 from $19 at Roth Capital 01/19/21 Fly Intel: Top five analyst upgrades GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 01/26/21 Piper Sandler Amarin in 'strong position' against Health Net, says Piper Sandler 01/20/21 UBS GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS 01/20/21 Fly Intel: Top five analyst downgrades 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 11/10/20 Vir Biotechnology reports Q3 EPS (67c), consensus (60c) 08/11/20 Vir Biotechnology reports Q2 EPS (27c), consensus (62c) LLY Eli Lilly $208.50 / -4.4 (-2.07%) 12/15/20 Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07 12/15/20 Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32 12/02/20 Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c 10/27/20 Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28 GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER 08 Jul VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 08/23/20 Health officials hopeful monoclonal antibodies can treat Covid, WSJ reports LLY Eli Lilly $208.50 / -4.4 (-2.07%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 10/06/20 Fly Intel: Wall Street's top stories for Tuesday 10/06/20 Fly Intel: Wall Street's top stories at midday LLY Eli Lilly $208.50 / -4.4 (-2.07%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 01/29/21 Eli Lilly - LLY 02/03/21 GlaxoSmithKline - GSK LLY GSK LLY Eli Lilly $208.50 / -4.4 (-2.07%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st
Hot Stocks	Boeing sees 2021 revenue improving from 2020 » 11:12 01/27/21 01/27 11:12 01/27/21 11:12 BA Boeing $196.20 / -5.88 (-2.91%) Sees improvement in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $196.20 / -5.88 (-2.91%) 11:12 Today Boeing: 2021 to continue to be challenging, but sees upward trends from 2020 11:11 Today Boeing operating cash 'much improved' in 2021 vs. 2020 11:03 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA 11:02 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA BA Boeing $196.20 / -5.88 (-2.91%) 01/20/21 Fly Intel: Top five analyst upgrades 01/20/21 Berenberg Boeing upgraded to Hold from Sell at Berenberg 01/04/21 Fly Intel: Top five analyst downgrades 01/04/21 Baird Boeing elevated to Fresh Pick at Baird BA Boeing $196.20 / -5.88 (-2.91%) 07:30 Today Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BA Boeing $196.20 / -5.88 (-2.91%) 01/25/21 Boeing 737 MAX set to take flight in Europe this week, Reuters reports 01/13/21 Emirates President: Boeing 777X entry likely in 2023 or later, Reuters says 01/13/21 Boeing's drone unit to pay $25M to settle civil fraud allegations, WSJ reports 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports BA Boeing $196.20 / -5.88 (-2.91%) 09:08 Today Fly Intel: Pre-market Movers 01/20/21 Netflix upgrades, Tesla target hike among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 10:30 Today Boeing - BA BA Boeing $196.20 / -5.88 (-2.91%) 12/07/20 Early notable gainers among liquid option names on December 7th 12/03/20 Unusually active option classes on open December 3rd 12/02/20 Boeing call volume above normal and directionally bullish 11/19/20 Notable open interest changes for November 19th

Events

Earnings calls, analyst events, roadshows and more

HESM
Today at 12:00

Hess Midstream Partners - HESM Conference Calls
Today at 12:00

Consumer Goods/Services Industry Meetings
HOPE
Today at 12:30

Hope Bancorp - HOPE Conference Calls
APH
Today at 13:00

Amphenol - APH Conference Calls
CPF
Today at 13:00

Central Pacific - CPF Conference Calls
Today at 13:00

Sustainability & ESG Research Industry Meetings
Today at 14:00

Prospects for 2021 and Beyond Government Event

Virtual Evemt
Today at 14:00

Closed Commission Meeting Government Event

Virtual Meeting
Today at 14:00

FOMC Announcement Government Event
AQMS
Today at 14:00

Aqua Metals - AQMS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SCPS X SCPS Scopus BioPharma IPO Managers: Benchmark, Joseph Gunnar Priced at: $9.00 1M Shares SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer Priced at: $25.00 77M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TIRX X TIRX Tian Ruixiang IPO Managers: Network 1 Financial Priced at: $4.00 3M Shares GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares CBIO X CBIO Catalyst Biosciences Spot Secondary Managers: Piper Sandler, Raymond James Priced at: $5.75 8.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DZSI X DZSI DZS Spot Secondary Managers: Stifel, Needham & B. Riley Securities Priced at: $14.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Spot Secondary Managers: Morgan Stanley Priced at: $65.00 28M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSNL X PSNL Personalis Spot Secondary Managers: Morgan Stanley, BofA, Citi & Cowen Priced at: $38.00 3.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum Priced at: $6.75 3.225M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	No deals
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares CALT X CALT Calliditas Therapeutics Secondary Managers: Citi, Jefferies & Stifel, Kempen & Co.,, LifeSci Capital, Carnegie $31.20 4.5M Shares DCT X DCT Duck Creek Technologies Secondary Managers: Goldman Sachs, JPMorgan & BofA $52.85 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Conduent management to meet virtually with Needham

TODAY'S FREE FLY STORIES

Get Full Fly Access